Effectiveness of Trimetazidine, a Cytoprotective Agent in Ischemic Heart Disease

The goal of metabolic medicines like trimetazidine is to provide cytoprotection in patients with ischemic heart disease (IHD) by inhibiting cardiac fatty acid oxidation and enhancing myocardial glucose utilisation. Trimetazidine is a potentially life-saving medicine that works by changing the metabolism of cardiac cells so that glucose instead of fat is used. To demonstrate the…
Read more

July 22, 2021 0